Description: Gufic Biosciences Limited manufactures and markets active pharmaceutical ingredients (APIs), generic pharmaceuticals, and related services in India, Africa, Asia, Europe, Australia, North America, South America, and internationally. It manufactures APIs and bulk drugs, such as antifungals, anesthetics, immuno suppressants, and intermediates for antifungals. The company also manufactures lyophilized injections, which include antibiotic, antifungal, cardiac medications, infertility treatments, antiviral solutions, and proton pump inhibitors (PPIs) segments. In addition, the company offers criti care, criticare life, ferticare, and spark pharmaceutical products; and herbal, aesthaderm, gufic stridden, and personal care products. It supplies its products to hospital chains and medical facilities. The company was founded in 1970 and is based in Mumbai, India.
Home Page: www.gufic.com
S.M. House
Mumbai,
400057
India
Phone:
91 22 6726 1000
Officers
Name | Title |
---|---|
Mr. Jayesh Pannalal Choksi | Chairman & MD |
Mr. Pranav Jayesh Choksi | CEO & Whole Time Director |
Mr. Pankaj Jayakumar Gandhi | Whole-Time Director |
Mr. Devkinandan B. Roonghta | Chief Financial Officer |
Mr. Nagesh Yarrabathina | Chief Operating Officer |
Ms. Ami Naresh Shah | Company Secretary, Compliance Officer & Legal Manager |
Mr. Pinak Padhya | Associate Vice President - Sales & Marketing |
Mr. Sunil Desai | Head ? Human Resource Department |
Mr. Ashok Laxman Dev | President of Operation |
Mr. Shekhar Tarabir Aley | Senior Vice President - Critical Care SBUs, Nepal & Institution |
Exchange: NSE
Country: IN : India
Currency: Indian Rupee (INR)
GIC Sector: | Health Care |
---|---|
GIC Group: | Pharmaceuticals, Biotechnology & Life Sciences |
GIC Industry: | Pharmaceuticals |
GIC Sub-Industry: | Pharmaceuticals |
Forward PE: | 0 |
---|---|
Trailing PE: | 52.6092 |
Price-to-Book MRQ: | 7.7822 |
Price-to-Sales TTM: | 5.4789 |
IPO Date: | |
Fiscal Year End: | March |
Full Time Employees: | 1491 |